Explosive growth outlook for iPhones, and mega merger in cannabis Explosive growth outlook for iPhones, and mega merger in cannabis Explosive growth outlook for iPhones, and mega merger in cannabis

Explosive growth outlook for iPhones, and mega merger in cannabis

Equities 6 minutes to read
Peter Garnry

Head of Saxo Strats

Summary:  In today's equity update we take a look at the news yesterday on explosive growth in iPhone production planned for next year sending Apple share sup 5% in yesterday's trading. However, the growth is not without risk as Apple has difficulties sourcing all the necessary components in another sign that the physical world has potentially reached a temporary limit for supporting growth without more investments and higher prices. We also take a look at the just announced merger between Aphria and Tilray creating the world's largest cannabis producer. While the metrics are the combined company and the industry are bad this merger might be what is needed to get economics of scale.

Apple shares were 5% higher yesterday pulling the equity market higher driven by a story from Nikkei News stating that the iPhone maker is planning to produce 96mn iPhones for the first half of next year significantly above the current Wall Street estimate. This production target translates into 30% growth y/y and will be a key driver behind the 15% revenue growth expected for the FY21 ending on 30 September 2021. While the news is positive for Apple has it expands and upgrade its ecosystem of iPhone users the real market value driver going forward is still the Services segment which has a higher profit margin and less capex needs. Apple is currently valued at a 3.5% free cash flow yield which is in line with other major technology companies such as Facebook and Microsoft.

Source: Saxo Group

A key risk for Apple’s ambitious production target is sourcing of key components. Competitors such as Xiaomi has also put up aggressive production targets for next year and thus everyone in the industry is scrambling to get enough components from semiconductors, memory chips and displays. This risk touches on something we have been talking about lately on our podcasts and presentations with clients. The physical world has reached a limit in its ability to service the demand that is coming through the digital world such as e-commerce, smartphones etc. The past 10 years growth in the digital world has sent signals to investors that they should invest there causing underinvestment in the physical world which is needed to support the online ecosystem. We see more and more signs that costs in the global supply chain is going up from agriculture, energy, shipping to metals. This is a theme we will be writing about tomorrow as this theme also plays into our positive view on emerging markets.

Aphria and Tilray are creating the world’s largest cannabis producer

Aphria and Tilray share are up 12% and 22% respectively in pre-market trading on news that the two cannabis producers are merging to create the world’s largest cannabis producer. The combined company would have generated $764mn in revenue, an EBITDA loss of $132mn and negative free cash flow of $502mn in the past 12 months. The raw numbers do not suggest an attractive company but rather two weak players combining with the hope of strength. This assessment might be too harsh but there is a grain of truth to this. However, on a positive not the combined company has 58% revenue growth y/y suggesting that through compounding the combined company will soon surpass $1bn in revenue and with that hopefully enough economics of scale to begin getting stable and positive operating margins. Prior to today’s market action the combined company would have an enterprise value of $4.56bn translating the equity valuation into an EV/Sales ratio of 6x which is rather high for a manufacturing type company in an industry that so far seems to be a commodity with no clear moats to protect shareholders.

Source: Saxo Group

We wrote about the cannabis industry back in February in our industry analysis Can the cannabis industry turn growth into profits?. In this piece we looked at the 22 largest public-listed companies and showed that the combined revenue at the time was $2.47bn generating a negative free cash flow of $3.15bn. These poor operating metrics had led to the leading cannabis index to be down almost 60% since September 2018. Since February not much as changed for the positive with the S&P/MX International Cannabis Index down 54% since inception and thus the industry has not experienced the same attention and speculative fever in 2020 as technology companies. Our view on the industry is still negative, but maybe 2021 is the year when economics of scale becomes evident and maybe this merger is what the industry needs.

Source: Bloomberg


The Saxo Group entities each provide execution-only service, and access to analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Inspiration Disclaimer and (v) Notices applying to Trade Inspiration, Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular, no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Select region


Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.